Tag: HighLife

HighLife Launches a New Large Annulus Valve in Ongoing Clinical Studies for Patients Suffering From Mitral Regurgitation

PARIS–(BUSINESS WIRE)–HighLife SAS, a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe mitral regurgitation (MR), announced today the introduction of a new valve size in its clinical trials, the Large Annulus Valve (LAV), designed for patients with larger anatomies. “HighLife’s […]

HighLife Closes a €32 Million Round B Financing

PARIS–(BUSINESS WIRE)–HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a €32 million round of equity financing. Proceeds from the financing will be used to complete the development of the company’s transcatheter transseptal mitral valve implantation program, which […]

HighLife Appoints Dr. Martin Rothman as Independent Member of the Board

PARIS–(BUSINESS WIRE)–HighLife SAS, a medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment of Dr. Martin T. Rothman as non-executive independent member of its Board of Directors. Dr. Rothman retired recently from his position as Vice President of medical affairs for coronary, structural […]

HighLife Appoints Jose Calle Gordo as Chairman of the Board

PARIS–(BUSINESS WIRE)–HighLife SAS, a medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment of Mr. Jose (“Pepe”) Calle Gordo as Chairman of its Board of Directors. Pepe brings 30 years of broad business and management experience in the medical device industry, having served […]

Early-Stage Medtech HighLife Nabs $14M for Transcatheter Mitral Valve Replacement

PARIS–(BUSINESS WIRE)– HighLife, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the closing of a €12.3 million investment round led by Sofinnova Partners which becomes the main investor in the company. HighLife had previously secured financing from LivaNova PLC, which also participated […]